G3BP2 and Parkinson disease: A Western blot analysis detected that PD patients expressed increased amounts of soluble and/or insoluble USP10, p62, G3BP2, poly(A)-binding protein (PABP) and HDAC6 relative to the controls (Fig. 8a).